Contraceptive Devices, Female

Displaying 1 - 2 of 2CSV
Heck, C. J., Kripke, K., Dam, A., Torres-Rueda, S., Bozzani, F., Obermeyer, C., Yohannes, K., Deacon, J., Meyers, K., Quigee, D., Wiant, S., Forsythe, S., Malati, C., Larson, M., Sobieszczyk, M. E., & Castor, D. (2024). Leveraging international stakeholders’ experiences with oral PrEP costs to accelerate implementation of the monthly dapivirine vaginal ring: A qualitative study. Health Research Policy and Systems, 22(1). https://doi.org/10.1186/s12961-024-01240-5
Publication Date
Philbin, M. M., & Perez-Brumer, A. (2022). Promise, perils and cautious optimism: the next frontier in long-acting modalities for the treatment and prevention of HIV. Current Opinion in HIV and AIDS, 17(2), 72–88. https://doi.org/10.1097/coh.0000000000000723
Publication Date